mCRPC
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
mCRPC
Sep 18, 2024, 11:25 |
Insight
Toni Choueiri: PEACE-3 phase 3 trials first results at ESMO24
Katy Beckermann, Assistant Professor Of Medicine, Vanderbilt University Medical Center, shared a post on X by…
Sep 7, 2024, 09:43 |
Insight
Metastatic castration - resistant prostate cancer resistant to androgen receptor signaling inhibitors - APCCC
APCCC posted on X: "Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated…
Jul 22, 2024, 15:17 |
Insight
Sean Khozin: Mapping the temporal and epigenetic dimensions of tumor evolution
Sean Khozin, Chief Executive Officer at CEO Roundtable on Cancer, shared on X: "The dynamic…
Jul 20, 2024, 21:28 |
Blog
Pedro C Barata: More awesome news for patient with mCRPC
Pedro C Barata, GU Med Oncologist at University Hospitals Seidman Cancer Center, posted on X:…
Jun 15, 2024, 14:37 |
Insight
Andy Hahn: Tweetorial for our phase II trial of pre-operative apalutamide monotherapy for localized IRPCa led by John W. Davis
Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Centre, shared on X: “Tweetorial for our…
Jun 15, 2024, 07:37 |
Blog
Saul Priceman: Phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC
Saul Priceman, Associate Professor at City of Hope, made the following post on X: "Proud…
Jun 11, 2024, 22:40 |
Blog
Rashid Sayyid: RW study of LuPSMA in VISION-eligible mCRPC patients
Rashid Sayyid, Urologic Oncology Clinical Fellow at University of Toronto, shared a post on X: "RW study of…
Jun 6, 2024, 10:53 |
Insight
Earle Burgess: The best part of the oral prostate cancer session at ASCO24
Earle Burgess, Genitourinary Medical Oncologist, Atrium Health Levine Cancer Institute, shared a post on LinkedIn: “What…
Jun 4, 2024, 04:53 |
Insight
Earle Burgess: Fascinating preliminary phase I trial data in mCRPC at ASCO24
Earle Burgess, Genitourinary Medical Oncologist at Atrium Health Levine Cancer Institute, shared a post on LinkedIn:…
May 20, 2024, 07:20 |
Insight
Florez Lab: ACS Journal Cancer highlights the Florez Lab's Pregnancy and Lung Cancer Registry
Florez Lab shared a post by ACS Journal Cancer, on X "Thank you to ACS…
May 14, 2024, 15:36 |
Insight
Andy Hahn: Congrats to Ana Aparicio and team on this trial of 192 men with mCRPC
Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared on X: “Congratulations to…
May 8, 2024, 07:21 |
Insight
Umang Swami: Prior NHT in patients with MCRPC
Umang Swami, Assistant Professor in the Department of Oncology at Huntsman Cancer Institute, shared on…
Apr 19, 2024, 20:03 |
Insight
Piotr Wysocki: BRCA1/2 mutations represent a poor prognostic factor for mCRCP patients - underscoring the need to use PARPi as soon as possible
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 15, 2024, 14:41 |
Drugs
Piotr Wysocki: The [177Lu]Lu-PSMA-617 plus enzalutamide combination is active and safe in mCRPC patients, but is it really an option for first-line treatment?
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Aug 22, 2023, 09:55 |
Drugs
Neeraj Agarwal: Breaking news: Glad to report the news from ph3 Contact-2 trial Cabozantinib + atezolizumab significantly improved outcomes in mCRPC prostate cancer.
Neeraj Agarwal stated on Twitter: "Breaking news: Glad to report the news from ph3 Contact-2 trial…
All:
15
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube